> top > docs > PubMed:24281730 > spans > 572-883 > annotations

PubMed:24281730 / 572-883 JSONTXT

Annnotations TAB JSON ListView MergeView

Inflammaging

Id Subject Object Predicate Lexical cue
T6 0-311 Sentence denotes We conducted a 32-week, double-blind, placebo-controlled, cross-over and randomized trial that implicated two arms: arm A, 20 patients received levocetirizine, montelukast with or without levocetirizine or placebo; arm B, 20 patients received desloratadine, montelukast with or without desloratadine or placebo.
T6 0-311 Sentence denotes We conducted a 32-week, double-blind, placebo-controlled, cross-over and randomized trial that implicated two arms: arm A, 20 patients received levocetirizine, montelukast with or without levocetirizine or placebo; arm B, 20 patients received desloratadine, montelukast with or without desloratadine or placebo.

luoyt2021_800_3

Id Subject Object Predicate Lexical cue
T6 258-269 CI denotes montelukast
T7 160-171 CI denotes montelukast
T25 144-158 CI denotes levocetirizine
T27 188-202 CI denotes levocetirizine
T28 243-256 CI denotes desloratadine
T29 286-299 CI denotes desloratadine

Linmchun_800_3

Id Subject Object Predicate Lexical cue
T4 144-158 CI denotes levocetirizine
T5 160-171 CI denotes montelukast
T6 188-202 CI denotes levocetirizine
T7 206-213 CI denotes placebo
T8 243-256 CI denotes desloratadine
T9 258-269 CI denotes montelukast
T10 286-299 CI denotes desloratadine
T11 303-310 CI denotes placebo